CCAAT/enhancer-binding protein alpha is a protein encoded by the CEBPA gene in humans. CCAAT/enhancer-binding protein alpha is a transcription factor...
11 KB (1,473 words) - 09:57, 3 June 2024
neoplasms with germline predisposition Acute myeloid leukaemia with germline CEBPA mutation Myeloid neoplasms with germline DDX41 mutation Myeloid neoplasms...
24 KB (2,329 words) - 06:57, 14 July 2024
study for their prognostic impact in AML. However, only FLT3-ITD, NPM1, CEBPA and c-KIT are currently included in validated international risk stratification...
75 KB (7,430 words) - 15:36, 9 August 2024
involving advanced liver cancer patients was launched for the saRNA drug MTL-CEBPA. It aimed to complete in 2021. Li, Long-Cheng; Okino, Steven T.; Zhao, Hong;...
9 KB (1,110 words) - 12:49, 8 August 2024
mutations have been implicated in cancer (e.g., mutations in genes p53, ATM, CEBPA, and PPARgamma). Marfan syndrome is caused by mutations in the FBN1 gene...
117 KB (13,924 words) - 09:15, 8 August 2024
ENSG00000131264 Homeodomain Known motif – High-throughput in vitro [94] VKTTTATKRCH CEBPA ENSG00000245848 bZIP Known motif – from protein with 100% identical DBD...
374 KB (81 words) - 02:10, 23 September 2023
kinase 2 has been shown to interact with: BRCA1, CDK2AP1, CDKN1B CDKN3, CEBPA, Cyclin A1, Cyclin E1, Flap structure-specific endonuclease 1, ORC1L, P21...
35 KB (4,314 words) - 00:26, 6 July 2024
Meshinchi, S (25 June 2009). "Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's...
32 KB (3,345 words) - 23:36, 20 July 2024
of the master regulators PPARγ and CCAAT/enhancer-binding protein alpha (CEBPA). This paves the way for possible genetic obesity treatments. Another class...
147 KB (16,686 words) - 18:26, 17 June 2024
neoplasms with germ line predisposition and organ dysfunction includes CEBPA/DDX41/RUNX1 disorders, GATA2 deficiency and SAMD9/9L syndromes. The goals...
64 KB (7,099 words) - 03:54, 30 July 2024